Preliminary research point out conolidine may perhaps inhibit precise ion channels, lowering neuronal excitability and limiting agony indicators. This system is particularly suitable in neuropathic soreness, where abnormal signaling will cause persistent distress. In addition, conolidine seems to impact G protein-coupled receptor (GPCR) pathways in